Search results
Results from the WOW.Com Content Network
It hasn't been the best quarter for Globus Medical, Inc. ( NYSE:GMED ) shareholders, since the share price has fallen...
Unfortunately for some shareholders, the Globus Medical (NYSE:GMED) share price has dived 31% in the last thirty days...
Globus Medical (NYSE: GMED) Q2 2024 Earnings Call Aug 06, 2024, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants. ... *Stock Advisor returns as of August 6, 2024.
Globus Medical, Inc. is a publicly traded medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders .
GMED earnings call for the period ending September 30, 2024.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Stock name Symbol Country of origin The Gabelli Convertible and Income Securities Fund, Inc. GCV: US The Gabelli Convertible and Income Securities Fund, Inc. GCV.PRB: US The Gabelli Dividend & Income Trust GDV: US The Gabelli Dividend & Income Trust GDV.PRA: US The Gabelli Dividend & Income Trust GDV.PRD: US The Gabelli Equity Trust Inc. GAB: US
Globus Medical's (GMED) Q1 preliminary sales results reflect an increase in procedural volumes along with growth in Enabling Technologies business.